Target intelligence / Profile preview

Peptide and protein substrates

Molecular classification
Other
01

Overview

Peptide and protein substrates refers to the broad class of amino acid-based molecules that serve as the functional reactants for enzymes such as kinases, proteases, and phosphatases. These molecules are essential for nearly all biological functions, including cellular signaling, metabolic regulation, and the maintenance of tissue structure (UniProt, 2024). In the context of pharmacology, this term is considered an "incorrect" or overly generic target designation because it encompasses thousands of distinct proteins rather than a single, specific therapeutic site (IUPHAR/BPS, 2023). Drugs typically interact with the enzymes that modify these substrates—such as protease inhibitors used in viral infections—or consist of the substrates themselves, as seen in hormone replacement therapies like insulin (PubMed, 2022). Because the category is so diverse, it lacks a unified mechanism of action or a specific safety profile. Effective drug development requires the identification of a specific protein or peptide within this group to ensure therapeutic precision and minimize off-target effects. Consequently, while these substrates are vital components of health and disease, they do not constitute a discrete target for drug discovery.

Other names
Polypeptide substratesProteinaceous substratesEnzymatic substratesProteic reactants
02

Mechanism of action

As a broad category, these molecules serve as the reactants for various enzymes; therapeutic strategies often involve inhibiting the enzymes that process them or providing synthetic versions of the substrates to restore physiological function.

03

Biological functions

Signal transductionMetabolismCellular structureImmune responseEnzymatic catalysis
04

Disease associations

CancerInfectionNeurodegenerative diseaseMetabolic disorderCardiovascular disease
05

Safety considerations

Lack of therapeutic specificityPotential for widespread off-target effectsImmunogenicity of exogenous proteinsSystemic toxicity due to broad biological impact
06

Interacting drugs

Insulin

3 more in the full profile.

07

Biomarkers

Specific protein concentrationsProteolytic fragmentsPhosphorylation statesPost-translational modifications

Beyond the preview

Go deeper on Peptide and protein substrates.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptide and protein substrates.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call